Technologies (Santa Clara, CA, USA). BL21 (DE3) pLysS chemical competent
cells were from Invitrogen. pET-15b and pET-28a plasmids for protein
expression were from Novagen (Madison, WI, USA). pET plasmids were
constructed for protein expression, including pET28a-Uba1, pET15b-UbcH7,
pET15b-UbcH5b, pET28a-E6AP, pGEX-4T-1-Parkin, pGEX-4T-1-HHARI, pET15b-UB,
and pET28a-Mpro. PINK1 was purchased from Boston Biochem
(AP-182–100). HEK293T cells were from American Tissue Culture
Collection (ATCC) and cultured in high-glucose Dulbecco’s modified
Eagles medium (DMEM) (Life Technologies, Carlsbad, CA, USA) with 10%
(v/v) fetal bovine serum (FBS) (Life Technologies). The anti-UB antibody
(sc-8017), anti-Myc antibody (sc-40), anti-HA antibody (sc-7392),
anti-GFP antibody (sc-9996), anti-E6AP antibody (sc-25509), anti-Parkin
antibody (sc-32282), and anti-β-actin antibody (sc-47778) were
from Santa Cruz Biotechnology. The anti-Flag M2 antibody (F3165) was
from Sigma-Aldrich. The anti-Mfn1 antibody (A9880), anti-Mfn2 antibody
(A12771), and Rabbit anti-GFP antibody (AE078) were from ABclonal
Technology. The antibodies were diluted between 500- and 1000-fold
to probe the Western blots.